Global Alzheimers Disease Treatment Market Size and Forecast 2023-2032|Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma,

The Alzheimer’s Disease Treatment Global Market Report 2023 by The Business Research Company, provides alzheimer’s disease treatment market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Alzheimer’s Disease Treatment Market:

According to The Business Research Company’s Alzheimer’s Disease Treatment Global Market Report 2023, the market size is expected to grow from $5.08 billion in 2022 to $5.48 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global alzheimer’s disease treatment is expected to grow from $7.37 billion in 2027 at a CAGR of 7.7%

The increasing cases of Alzheimer’s are a major factor contributing to the growth of the alzheimer’s disease treatment market. Alzheimer’s is the most common type of dementia. The USA Alzheimer’s Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s patients by 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s are expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of alzheimer’s disease is expected to drive the demand of the growth of global alzheimer’s disease treatment market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

The alzheimer’s disease treatment market is segmented:

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulin

2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists

3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

Increasing R&D investments and collaborations as a result of emerging treatment technologies is the alzheimer’s disease (AD) treatment market key trends. The Alzheimer’s Association is assisting with funds to researchers in search of innovative therapeutic approaches and seeks more government funding for Alzheimer’s studies. Technologies such as ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and anti-amyloid inhibitors are emerging in the AD market. For instance, Comentis and Astellas collaborated and entered the BACE inhibitor field with their peptidomimetic series. Manufacturing firms such as AC Immune, Adamas Pharmaceuticals, INmune Bio, Intra-Cellular Therapies, and vTv Therapeutics are focusing more on R&D investments with their research molecules in clinical trials to achieve a breakthrough in the treatment of alzheimer’s disease.

The alzheimer’s disease treatment market report table of contents includes:

1. Executive Summary

2. Alzheimer’s Disease Treatment Market Characteristics

3. Alzheimer’s Disease Treatment Market Trends And Strategies

4. Alzheimer’s Disease Treatment Market – Macro Economic Scenario

5. Alzheimer’s Disease Treatment Market Size And Growth




26. Africa Alzheimer’s Disease Treatment Market

27. Alzheimer’s Disease Treatment Market Competitive Landscape And Company Profiles

28. Alzheimer’s Disease Treatment Pipeline Analysis

29. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market

30. Alzheimer’s Disease Treatment Market Future Outlook and Potential Analysis

Top Major Players:

  • Allergan
  • Eisai Co. Ltd
  • Novartis AG
  • Pfizer Inc
  • Merz Pharma

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:






Healthcare Blog:

Global Market Model: